M Stanková Selected Research

M Stanková Research Topics

2	Toxoplasmosis 02/2009 - 12/2007
1	Adenocarcinoma of Lung 01/2010
1	Adenocarcinoma 01/2010
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 01/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2010
1	Heart Diseases (Heart Disease) 01/2010
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2010
1	Peripheral Arterial Disease 01/2010
1	Cytomegalovirus Infections (Inclusion Disease) 11/2009
1	Cerebral Toxoplasmosis 02/2009
1	HIV Infections (HIV Infection) 12/2007
1	Disease Progression 01/2005
1	Infections 01/2003

1	Tyrosine Kinase InhibitorsIBA 01/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2010
1	Gefitinib (Iressa)FDA Link 01/2010
1	CCAAT-Enhancer-Binding Protein-alphaIBA 01/2010
1	Cytostatic AgentsIBA 01/2010
1	ErbB Receptors (EGF Receptor)IBA 01/2010
1	Glycoproteins (Glycoprotein)IBA 11/2009
1	Complement System Proteins (Complement)IBA 02/2009
1	AntibodiesIBA 02/2009
1	Immunoglobulin M (IgM)IBA 02/2009
1	Reverse Transcriptase InhibitorsIBA 01/2005
1	Peptide Hydrolases (Proteases)FDA Link 01/2005
1	Biomarkers (Surrogate Marker)IBA 01/2003

3	Therapeutics 01/2010 - 12/2007
1	Secondary Prevention 01/2010